BioFlyte Awarded SBIR Phase I Contract by U.S. Air Force to Advance its Aerosol Chem/Biothreat Detection and Identification Technology for Critical Infrastructure

BioFlyte has been selected by AFWERX for a Small Business Innovation Research (SBIR) Phase I contract focused on its BioTOF™ z200 dynamic threat monitoring solution to address challenges within critical infrastructure protection.

The goal of the program is to demonstrate the ability of BioFlyte’s aerosol threat detection and identification technology to protect both military personnel and infrastructure from known and emerging biological and chemical threats. BioFlyte’s BioTOF z200 is the first dynamic threat monitoring solution that is capable of early warning detection, analysis, and confirmatory identification across both the chemical and biological threat landscape. BioTOF has been proven to detect and identify all classes of particulate threats, including bacteria, viruses, biotoxins like anthrax and ricin, and pharmaceutical-based agents like fentanyl. Each test, from collection to alarm, is completed within approximately 5 minutes.

“As the threat landscape continues to evolve, critical infrastructure protection and homeland security are top of mind for our leaders in government and the military,” said Todd Sickles, CEO of BioFlyte. “We are honored to bring our life-saving threat detection and identification technology to the U.S. military through this award. We believe our scalable and powerful technology can help keep military personnel safe from dangerous chemical and biological threats.”

The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution.